Extract from the Register of European Patents

EP About this file: EP2930176

EP2930176 - HYDANTOIN DERIVATIVE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.12.2018
Database last updated on 30.03.2026
FormerThe patent has been granted
Status updated on  05.01.2018
FormerGrant of patent is intended
Status updated on  10.07.2017
FormerRequest for examination was made
Status updated on  27.06.2017
FormerGrant of patent is intended
Status updated on  01.02.2017
Most recent event   Tooltip14.12.2018No opposition filed within time limitpublished on 16.01.2019  [2019/03]
Applicant(s)For all designated states
Chugai Seiyaku Kabushiki Kaisha
5-1, Ukima 5-chome Kita-ku
Tokyo 115-8543 / JP
[2015/42]
Inventor(s)01 / NISHIMURA, Yoshikazu
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
135 Komakado 1-chome
Gotemba-shi Shizuoka 412-8513 / JP
02 / ESAKI, Toru
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
135 Komakado 1-chome
Gotemba-shi Shizuoka 412-8513 / JP
03 / TAMURA, Tatsuya
c/o CHUGAI SEIYAKU KABUSHIKI KAISHA
135 Komakado 1-chome
Gotemba-shi Shizuoka 412-8513 / JP
 [2015/42]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2015/42]
Application number, filing date13862318.610.12.2013
[2015/42]
WO2013JP83022
Priority number, dateJP2012026917810.12.2012         Original published format: JP 2012269178
[2015/42]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014092061
Date:19.06.2014
Language:JA
[2014/25]
Type: A1 Application with search report 
No.:EP2930176
Date:14.10.2015
Language:EN
[2015/42]
Type: B1 Patent specification 
No.:EP2930176
Date:07.02.2018
Language:EN
[2018/06]
Search report(s)International search report - published on:JP19.06.2014
(Supplementary) European search report - dispatched on:EP02.05.2016
ClassificationIPC:C07D471/10, A61K31/438, A61P3/14, A61P5/18, A61P43/00, C07D519/00
[2015/42]
CPC:
C07D471/10 (EP,CN,RU,US); A61K31/438 (RU); A61P19/00 (EP);
A61P3/00 (EP); A61P3/14 (EP,RU); A61P43/00 (EP,RU);
A61P5/00 (EP); A61P5/18 (EP,RU); C07D491/10 (RU);
C07D519/00 (EP,CN,RU,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/42]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:HYDANTOINDERIVATE[2015/42]
English:HYDANTOIN DERIVATIVE[2015/42]
French:DÉRIVÉ D'HYDANTOÏNE[2015/42]
Entry into regional phase02.07.2015Translation filed 
02.07.2015National basic fee paid 
02.07.2015Search fee paid 
02.07.2015Designation fee(s) paid 
02.07.2015Examination fee paid 
Examination procedure02.07.2015Amendment by applicant (claims and/or description)
02.07.2015Examination requested  [2015/42]
02.02.2017Communication of intention to grant the patent
12.06.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.06.2017Fee for grant paid
12.06.2017Fee for publishing/printing paid
11.07.2017Communication of intention to grant the patent
08.11.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.02.2017
Opposition(s)08.11.2018No opposition filed within time limit [2019/03]
Fees paidRenewal fee
22.12.2015Renewal fee patent year 03
23.12.2016Renewal fee patent year 04
21.12.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY07.02.2018
EE07.02.2018
SM07.02.2018
[2018/52]
Former [2018/50]CY07.02.2018
EE07.02.2018
Former [2018/37]CY07.02.2018
Documents cited:Search  No further relevant documents disclosed
by applicantWO2010126030
   KRONENBERG, H.M. ET AL.: "Handbook of Experimental Pharmacology", 1993, SPRINGER-VERLAG, pages: 185 - 201
   TASHJIAN; GAGEL, J. BONE MINER. RES., vol. 21, 2006, pages 354 - 365
   REJNMARK ET AL., OSTEOPOROSIS INT., 27 November 2012 (2012-11-27)
   WINER KK ET AL., J. CLIN. ENDOCRINOL. METAB., vol. 88, no. 9, 2003, pages 4214 - 4220
   J. BONE, MINER. RES., vol. 14, 1999, pages 11 - 20
   T. KRONBACH ET AL.: "Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4", MOL. PHARMACOL, vol. 36, no. 1, 1989, pages 89 - 96
   CHEMISTRY-A EUROPEAN JOURNAL, vol. 8, no. 2, 2002, pages 439 - 450
   TAKASU ET AL., J. BONE. MINER. RES., vol. 14, 1999, pages 11 - 20
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.